We recently reported that Numb knockdown decreased chemosensitivity by down-regulating p53 expression in pancreatic cancer [34], and SRPK2 regulated cell migration, invasion and chemosensitivity via the Numb and p53 signaling pathway [15]. The gene discussed is SRPK2; the disease is familial pancreatic carcinoma.